Goldman Sachs’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178M | Buy |
545,316
+121,949
| +29% | +$39.8M | 0.02% | 526 |
|
|
2025
Q1 | $114M | Buy |
423,367
+116,912
| +38% | +$31.6M | 0.02% | 629 |
|
|
2024
Q4 | $72.1M | Sell |
306,455
-49,645
| -14% | -$11.7M | 0.01% | 843 |
|
|
2024
Q3 | $97.9M | Sell |
356,100
-158,567
| -31% | -$43.6M | 0.02% | 683 |
|
|
2024
Q2 | $125M | Buy |
514,667
+254,648
| +98% | +$61.9M | 0.02% | 599 |
|
|
2024
Q1 | $38.9M | Sell |
260,019
-31,349
| -11% | -$4.69M | 0.01% | 1120 |
|
|
2023
Q4 | $55.8M | Sell |
291,368
-20,677
| -7% | -$3.96M | 0.01% | 932 |
|
|
2023
Q3 | $55.3M | Buy |
312,045
+56,152
| +22% | +$9.94M | 0.01% | 885 |
|
|
2023
Q2 | $48.6M | Buy |
255,893
+25,707
| +11% | +$4.88M | 0.01% | 967 |
|
|
2023
Q1 | $46.1M | Sell |
230,186
-162,575
| -41% | -$32.6M | 0.01% | 963 |
|
|
2022
Q4 | $93.3M | Sell |
392,761
-72,546
| -16% | -$17.2M | 0.02% | 636 |
|
|
2022
Q3 | $93.1M | Sell |
465,307
-12,067
| -3% | -$2.42M | 0.02% | 635 |
|
|
2022
Q2 | $69.6M | Sell |
477,374
-204,179
| -30% | -$29.8M | 0.02% | 780 |
|
|
2022
Q1 | $111M | Sell |
681,553
-5,142
| -0.7% | -$840K | 0.02% | 609 |
|
|
2021
Q4 | $116M | Buy |
686,695
+20,240
| +3% | +$3.43M | 0.02% | 611 |
|
|
2021
Q3 | $126M | Sell |
666,455
-35,591
| -5% | -$6.72M | 0.03% | 533 |
|
|
2021
Q2 | $119M | Buy |
702,046
+7,736
| +1% | +$1.31M | 0.03% | 546 |
|
|
2021
Q1 | $98M | Sell |
694,310
-19,075
| -3% | -$2.69M | 0.02% | 591 |
|
|
2020
Q4 | $92.7M | Buy |
713,385
+125,825
| +21% | +$16.4M | 0.02% | 576 |
|
|
2020
Q3 | $85.5M | Sell |
587,560
-497,516
| -46% | -$72.4M | 0.02% | 570 |
|
|
2020
Q2 | $161M | Buy |
1,085,076
+304,814
| +39% | +$45.1M | 0.05% | 349 |
|
|
2020
Q1 | $84.9M | Sell |
780,262
-57,442
| -7% | -$6.25M | 0.03% | 527 |
|
|
2019
Q4 | $96.5M | Sell |
837,704
-309,664
| -27% | -$35.7M | 0.02% | 649 |
|
|
2019
Q3 | $92.3M | Buy |
1,147,368
+227,197
| +25% | +$18.3M | 0.03% | 649 |
|
|
2019
Q2 | $66.8M | Sell |
920,171
-96,842
| -10% | -$7.03M | 0.02% | 872 |
|
|
2019
Q1 | $95M | Sell |
1,017,013
-102,375
| -9% | -$9.57M | 0.03% | 636 |
|
|
2018
Q4 | $81.6M | Buy |
1,119,388
+178,810
| +19% | +$13M | 0.03% | 665 |
|
|
2018
Q3 | $82.3M | Buy |
940,578
+111,679
| +13% | +$9.77M | 0.02% | 800 |
|
|
2018
Q2 | $81.6M | Sell |
828,899
-181,839
| -18% | -$17.9M | 0.02% | 798 |
|
|
2018
Q1 | $120M | Sell |
1,010,738
-176,806
| -15% | -$21.1M | 0.03% | 607 |
|
|
2017
Q4 | $151M | Sell |
1,187,544
-606,207
| -34% | -$77M | 0.04% | 519 |
|
|
2017
Q3 | $211M | Buy |
1,793,751
+282,039
| +19% | +$33.1M | 0.05% | 341 |
|
|
2017
Q2 | $121M | Buy |
1,511,712
+127,718
| +9% | +$10.2M | 0.03% | 572 |
|
|
2017
Q1 | $70.9M | Buy |
1,383,994
+469,557
| +51% | +$24.1M | 0.02% | 829 |
|
|
2016
Q4 | $34.2M | Sell |
914,437
-28,422
| -3% | -$1.06M | 0.01% | 1202 |
|
|
2016
Q3 | $63.9M | Buy |
942,859
+249,691
| +36% | +$16.9M | 0.02% | 832 |
|
|
2016
Q2 | $38.5M | Buy |
693,168
+51,294
| +8% | +$2.85M | 0.01% | 1055 |
|
|
2016
Q1 | $40.3M | Buy |
641,874
+248,739
| +63% | +$15.6M | 0.01% | 1019 |
|
|
2015
Q4 | $37M | Buy |
393,135
+67,369
| +21% | +$6.34M | 0.01% | 1051 |
|
|
2015
Q3 | $26.2M | Sell |
325,766
-59,811
| -16% | -$4.81M | 0.01% | 1161 |
|
|
2015
Q2 | $46.2M | Sell |
385,577
-209,528
| -35% | -$25.1M | 0.01% | 903 |
|
|
2015
Q1 | $62.1M | Buy |
595,105
+38,829
| +7% | +$4.05M | 0.02% | 734 |
|
|
2014
Q4 | $54M | Sell |
556,276
-14,829
| -3% | -$1.44M | 0.02% | 760 |
|
|
2014
Q3 | $44.6M | Buy |
571,105
+7,994
| +1% | +$624K | 0.01% | 848 |
|
|
2014
Q2 | $35.6M | Buy |
563,111
+50,522
| +10% | +$3.19M | 0.01% | 996 |
|
|
2014
Q1 | $34.4M | Buy |
512,589
+71,839
| +16% | +$4.82M | 0.01% | 965 |
|
|
2013
Q4 | $28.3M | Buy |
440,750
+91,961
| +26% | +$5.91M | 0.01% | 1044 |
|
|
2013
Q3 | $22.3M | Sell |
348,789
-203,530
| -37% | -$13M | 0.01% | 1069 |
|
|
2013
Q2 | $17.1M | Buy |
+552,319
| New | +$17.1M | 0.01% | 1133 |
|